机译:AZD9977,一种新颖,选择性矿物质激素受体调节剂临床安全,耐受性,药代动力学和对尿液电解质排泄的影响
Early Clinical Development Innovative Medicines and Early Development Biotech;
PAREXEL Early Phase Clinical Unit Northwick Park HospitalWatford Road Harrow HA1 3UJ UK;
PAREXEL Early Phase Clinical Unit Northwick Park HospitalWatford Road Harrow HA1 3UJ UK;
Early Clinical Development Innovative Medicines and Early Development Biotech;
Early Clinical Development Innovative Medicines and Early Development Biotech;
Early Clinical Development Innovative Medicines and Early Development Biotech;
Cardiovascular and Metabolic Disease Innovative Medicine Unit Innovative Medicines and Early;
Early Clinical Development Innovative Medicines and Early Development Biotech;
Early Clinical Development Innovative Medicines and Early Development Biotech;
Cardiovascular and Metabolic Disease Innovative Medicine Unit Innovative Medicines and Early;
Cardiovascular and Metabolic Disease Innovative Medicine Unit Innovative Medicines and Early;
aldosterone; AZD9977; eplerenone; fludrocortisone; mineralocorticoid receptor; mineralocorticoid receptor modulator;
机译:AZD9977,一种新颖的选择性矿物质激素受体调节剂对AZD9977的泌尿电解质排泄的临床安全性,耐受性,药代动力学和影响
机译:在健康男性中矿物皮质激素受体调节剂AZD9977的安全性,耐受性和药代动力学:I阶段我多个上升剂量研究
机译:新型选择性盐皮质激素受体拮抗剂氟雷农的药代动力学,安全性和耐受性-人体及相关生物利用度研究的结果
机译:在日托中心就诊后的663名儿童中,尿液中邻苯二甲酸酯代谢物的排泄与每日可容许摄入的邻苯二甲酸盐相比
机译:新型非甾体类盐皮质激素受体阻滞剂埃塞米酮(CS-3150)对低肾素Dahl盐敏感性高血压大鼠血压和尿中血管紧张素原的影响
机译:新型选择性盐皮质激素受体调节剂AZD9977的临床安全性耐受性药代动力学及其对尿电解质排泄的影响
机译:AZD9977的临床前药理学:一种新型矿物质激素受体调节剂分离器官免受电解质排泄的影响